Actavis Inc (ACT) 188.83 $ACT
Facebook, Arris, Grifols Initiate New Bases
at Investor's Business Daily - Fri Apr 11, 5:35PM CDT
With the stock market in a correction, the investor should emphasize defense. This means keeping cash in the portfolio, cutting losses on any stocks that are falling fast, and taking at least some profits on stocks that trigger key sell signals....
Acura Pharma Ends Agreement with Pfizer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 4:35PM CDT
Acura Pharmaceuticals entered into a letter agreement with Pfizer in connection with its license agreement for Oxecta.
3 Health Care Stocks Moving The Sector Upward
at The Street - Fri Apr 11, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), The Medicines Company (NASDAQ: MDCO), Hospira, Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP), and Galectin Therapeutics Inc. (NASDAQ: GALT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Regulatory Update from Forest Labs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 3:40PM CDT
Forest Labs and partner Almirall announced that the FDA has provided a feedback on their new drug application (NDA) for the fixed dose combination of Tudorza (aclidinium) and formoterol.
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
PR Newswire - Thu Apr 10, 11:30AM CDT
On Wednesday, April 09, 2014, the NASDAQ Composite ended at 4,183.90, up 1.72%, the Dow Jones Industrial Average advanced 1.11% to 16,437.18, and the S&P 500 closed at 1,872.18, up 1.09%. The gains were broad based as eight out of 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 673.27, up 2.11%, while the same has declined 2.01% in the last one month. Investor-Edge has initiated coverage on the following equities: Mylan Inc. (NASDAQ: MYL), Actavis PLC (NYSE: ACT), Hospira Inc. (NYSE: HSP) and The Medicines Co. (NASDAQ: MDCO). Free technical research on MYL, ACT, HSP and MDCO can be downloaded upon signing up at:
Stocks Add To Gains; Intuitive Surgical Slumps On Warning
at Investor's Business Daily - Wed Apr 09, 11:04AM CDT
Stocks extended gains Wednesday after Tuesday's lower-volume rally. About two hours into the session, the Nasdaq led the way, up 0.5%. The Dow Jones industrial average and S&P 500 added 0.2% each. NYSE and Nasdaq volume was tracking considerably...
Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:37AM CDT
Mallinckrodt plc as the company saw its shares rise more than 5% on the day.
Alexion, Biogen Among Leading Big-Cap Biotechs
at Investor's Business Daily - Wed Apr 09, 7:02AM CDT
Growth stocks are taking a hit now that the market is in a correction. Biotechs saw a recent sell-off over concerns that the sector was overheating, but biotechs and medical stocks are among leading big-cap stocks. IBD's Big Cap Screen of the Day...
Upcoming Results and Conference Call Schedules, New Office Facility, and Stock Price Movements-Analyst Notes on Biogen, Actavis, Bristol-Myers, AbbVie, and Baxter
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Actavis Plc (NYSE: ACT), Bristol-Myers Squibb Co. (NYSE: BMY), AbbVie Inc. (NYSE: ABBV), and Baxter International Inc. (NYSE: BAX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Pacira and Patheon Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 5:10PM CDT
Pacira has signed a strategic co-production partnership deal with Patheon.
Additional Data on Pacira's Exparel - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 4:20PM CDT
Pacira announced additional phase III data on its lead product, Exparel.
Stocks Higher In Late Afternoon; First Solar Jumps
at Investor's Business Daily - Tue Apr 08, 2:02PM CDT
The Nasdaq outperformed in late afternoon trading Tuesday, but gains in the other major indexes were fading. The Nasdaq rose 0.5%, the S&P 500 gained 0.2% and the Dow Jones industrial average slipped 0.1%. NYSE volume was tracking slightly higher...
Stocks Rally, Stall, Turn Mixed; Consol Energy, U.S. Steel Jump
at Investor's Business Daily - Tue Apr 08, 9:29AM CDT
Early gains quickly flickered into a mixed performance Tuesday, with China-based stocks grabbing a large share of early gains. The Nasdaq bobbed to a 0.2% gain. The S&P 500 eased 0.1%. The Dow Jones industrial average dipped 0.2%. Volume was mixed,...
Caesarstone, Other Leaders Show Supporting Action
at Investor's Business Daily - Fri Apr 04, 4:49PM CDT
Even as market volatility increased in recent weeks, some leaders have managed to find support at their 10-week lines or are close to that key moving average. Caesarstone (CSTE) found support at its 10-week moving average two weeks ago. It tested the...
Mylan Rejected In Bid To Acquire Sweden's Meda
at Investor's Business Daily - Fri Apr 04, 11:27AM CDT
Generic-drug giant Mylan (MYL) on Friday lost out in a takeover bid for Swedish counterpart Meda, but its stock was still up more than 4% in midday trading on the stock market. Late Thursday, Britain's Financial Times reported that Mylan and Meda...
Actavis Up Slightly on Silom Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 2:56PM CDT
Actavis acquired Thailand-based generic company, Silom Medical Company.
Actavis inaugurates new regional headquarters in Singapore for APACA
M2 - Thu Apr 03, 5:36AM CDT
Pharmaceutical company, Actavis (NYSE:ACT) reported on Wednesday the official opening of its new regional headquarters in Singapore for its Asia Pacific and Africa (APACA) region under its global expansion strategy.
Actavis Launches Asia Pacific Regional Headquarters in Singapore
PR Newswire - Wed Apr 02, 7:00PM CDT
Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region.
Four Top World Stocks Offer Follow-On Buy Points
at Investor's Business Daily - Wed Apr 02, 5:11PM CDT
The market's resumed uptrend doesn't come with the clean slate that a sharp correction followed by a follow-through day would offer. A striking eight distribution days levied against the Nasdaq hold out a bright red flag for investors. But the shift...
Facebook, Arris, Grifols Initiate New Bases
at Investor's Business Daily - Fri Apr 11, 5:35PM CDT
With the stock market in a correction, the investor should emphasize defense. This means keeping cash in the portfolio, cutting losses on any stocks that are falling fast, and taking at least some profits on stocks that trigger key sell signals....
Acura Pharma Ends Agreement with Pfizer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 4:35PM CDT
Acura Pharmaceuticals entered into a letter agreement with Pfizer in connection with its license agreement for Oxecta.
3 Health Care Stocks Moving The Sector Upward
at The Street - Fri Apr 11, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), The Medicines Company (NASDAQ: MDCO), Hospira, Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP), and Galectin Therapeutics Inc. (NASDAQ: GALT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Regulatory Update from Forest Labs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 3:40PM CDT
Forest Labs and partner Almirall announced that the FDA has provided a feedback on their new drug application (NDA) for the fixed dose combination of Tudorza (aclidinium) and formoterol.
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
PR Newswire - Thu Apr 10, 11:30AM CDT
On Wednesday, April 09, 2014, the NASDAQ Composite ended at 4,183.90, up 1.72%, the Dow Jones Industrial Average advanced 1.11% to 16,437.18, and the S&P 500 closed at 1,872.18, up 1.09%. The gains were broad based as eight out of 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 673.27, up 2.11%, while the same has declined 2.01% in the last one month. Investor-Edge has initiated coverage on the following equities: Mylan Inc. (NASDAQ: MYL), Actavis PLC (NYSE: ACT), Hospira Inc. (NYSE: HSP) and The Medicines Co. (NASDAQ: MDCO). Free technical research on MYL, ACT, HSP and MDCO can be downloaded upon signing up at:
Stocks Add To Gains; Intuitive Surgical Slumps On Warning
at Investor's Business Daily - Wed Apr 09, 11:04AM CDT
Stocks extended gains Wednesday after Tuesday's lower-volume rally. About two hours into the session, the Nasdaq led the way, up 0.5%. The Dow Jones industrial average and S&P 500 added 0.2% each. NYSE and Nasdaq volume was tracking considerably...
Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:37AM CDT
Mallinckrodt plc as the company saw its shares rise more than 5% on the day.
Alexion, Biogen Among Leading Big-Cap Biotechs
at Investor's Business Daily - Wed Apr 09, 7:02AM CDT
Growth stocks are taking a hit now that the market is in a correction. Biotechs saw a recent sell-off over concerns that the sector was overheating, but biotechs and medical stocks are among leading big-cap stocks. IBD's Big Cap Screen of the Day...
Upcoming Results and Conference Call Schedules, New Office Facility, and Stock Price Movements-Analyst Notes on Biogen, Actavis, Bristol-Myers, AbbVie, and Baxter
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Actavis Plc (NYSE: ACT), Bristol-Myers Squibb Co. (NYSE: BMY), AbbVie Inc. (NYSE: ABBV), and Baxter International Inc. (NYSE: BAX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Pacira and Patheon Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 5:10PM CDT
Pacira has signed a strategic co-production partnership deal with Patheon.
Additional Data on Pacira's Exparel - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 4:20PM CDT
Pacira announced additional phase III data on its lead product, Exparel.
Stocks Higher In Late Afternoon; First Solar Jumps
at Investor's Business Daily - Tue Apr 08, 2:02PM CDT
The Nasdaq outperformed in late afternoon trading Tuesday, but gains in the other major indexes were fading. The Nasdaq rose 0.5%, the S&P 500 gained 0.2% and the Dow Jones industrial average slipped 0.1%. NYSE volume was tracking slightly higher...
Stocks Rally, Stall, Turn Mixed; Consol Energy, U.S. Steel Jump
at Investor's Business Daily - Tue Apr 08, 9:29AM CDT
Early gains quickly flickered into a mixed performance Tuesday, with China-based stocks grabbing a large share of early gains. The Nasdaq bobbed to a 0.2% gain. The S&P 500 eased 0.1%. The Dow Jones industrial average dipped 0.2%. Volume was mixed,...
Caesarstone, Other Leaders Show Supporting Action
at Investor's Business Daily - Fri Apr 04, 4:49PM CDT
Even as market volatility increased in recent weeks, some leaders have managed to find support at their 10-week lines or are close to that key moving average. Caesarstone (CSTE) found support at its 10-week moving average two weeks ago. It tested the...
Mylan Rejected In Bid To Acquire Sweden's Meda
at Investor's Business Daily - Fri Apr 04, 11:27AM CDT
Generic-drug giant Mylan (MYL) on Friday lost out in a takeover bid for Swedish counterpart Meda, but its stock was still up more than 4% in midday trading on the stock market. Late Thursday, Britain's Financial Times reported that Mylan and Meda...
Actavis Up Slightly on Silom Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 2:56PM CDT
Actavis acquired Thailand-based generic company, Silom Medical Company.
Actavis inaugurates new regional headquarters in Singapore for APACA
M2 - Thu Apr 03, 5:36AM CDT
Pharmaceutical company, Actavis (NYSE:ACT) reported on Wednesday the official opening of its new regional headquarters in Singapore for its Asia Pacific and Africa (APACA) region under its global expansion strategy.
Actavis Launches Asia Pacific Regional Headquarters in Singapore
PR Newswire - Wed Apr 02, 7:00PM CDT
Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region.
Four Top World Stocks Offer Follow-On Buy Points
at Investor's Business Daily - Wed Apr 02, 5:11PM CDT
The market's resumed uptrend doesn't come with the clean slate that a sharp correction followed by a follow-through day would offer. A striking eight distribution days levied against the Nasdaq hold out a bright red flag for investors. But the shift...
